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Abstract
Purpose: To determine the number of specimens to be obtained from pulmonary lesions to get the highest possible accuracy in histo-
logical work-up.
Materials and methods: A retrospective evaluation (January 1999 to April 2004) covered 260 patients with thoracic lesions who 
underwent computer tomography (CT)-guided core-cut biopsy in coaxial technique. All biopsies were performed utilizing a 19 gauge 
introducer needle and a 20 gauge core-cut biopsy needle. In all, 669 usable biopsies were taken (from 1–5 biopsies in each setting). The 
specimens were marked sequentially and each biopsy was worked up histologicaly. The biopsy results were correlated to histology after 
surgery, clinical follow-up or autopsy. The number of biopsies was determined that is necessary to achieve the highest possible accuracy 
in diagnosing pulmonary lesions.
Results: In 591 of 669 biopsies (88.3%), there were correct positive results. The overall accuracy was 87.4%. In 193 of 260 (74.2%) 
patients, a suspected malignancy was confirmed. In 50 of 260 (19.2%) patients, a benign lesion was correctly diagnosed. Seventeen 
(6.5%) patients were lost to follow-up. The first, second and third biopsies had cumulative accuracies of 63.6%, 89.2% and 91.5%, 
respectively (P , 0.02). More biopsies did not show any higher impact on accuracy.
Conclusion: For the highest possible accuracy in diagnosing pulmonary lesions by CT-guided core-cut biopsy, at least three usable 
specimens are recommended to be taken.
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Introduction
Computed  tomography  (CT)  scan-guided  biopsy 
of thoracic lesions is a widely accepted diagnostic 
  technique.1  Previously,  CT  scan-guided  biopsies 
were usually performed with fine-needle aspiration 
and cytological examination to differentiate malig-
nant from benign lesions.2,3 A further development is 
tissue core biopsy using a cutting needle; this allows 
histopathological  evaluation  of  the  specimen.4 An 
automated  spring-driven  cutting  needle  for  tissue-
core biopsy has made it easier to obtain   satisfactory 
specimens for histological analysis.5–7 Percutaneous 
transthoracic biopsy is now more widely performed 
with  helical  CT-scanning;2  however,  there  are 
other modalities employed for this imaging guided 
procedure  such  as  fluoroscopy  and  conventional 
CT-scanning.1–3
We are unaware of reports in the literature deal-
ing  with  the  number  of  biopsies  in  pulmonary 
lesions required for an accurate histological work 
up. Therefore, the purpose of our study was to anal-
yse, whether the number of biopsy specimen taken 
has an impact on diagnostic accuracy at histologic 
examination.
Materials and Methods
subjects
From  January  1999  to  April  2004,  260  patients 
(mean  age  of  the  patients  was  64.3  years  (range 
35–82 years; 158 men and 102 women)) with pulmo-
nary lesions underwent CT-guided core-cut biopsy at 
our institution. Overall, 669 biopsies were obtained, 
1–5 biopsies from each patient at the radiologists’s 
discretion. None of the patients had severe chronic 
obstructive disease (COPD), severe emphysema or 
a coagulopathy. All patients gave written informed 
consent.
Biopsy needle
Core-cut biopsy in coaxial technique was performed 
with  a  20-gauge  needle  (Manan®  biopsy  needle, 
Gainsville  Florida).  The Auto  Surecut  system  (Pro 
Mag 2.2 Manan®) consists of an outer cutting cannula 
with a coring point and a  trocar with a sharp  tip. 
A closed microsyringe is attached to the outer cutting 
cannula inside the body of the cutting needle device. 
The outer cutting cannula is automatically extended 
to a length of 2.2 cm. At the same time, a vacuum is 
established in the biopsy canal; the tissue biopsy is 
obtained by negative pressure at the tip of the outer 
cannula.
Biopsy procedure
Before undergoing biopsy all patients had diagnostic 
helical CT scans (Lightspeed GE, Wisconsin, USA) 
of the chest with 5 mm slice thickness. These pre-
liminary  images  were  reviewed  to  plan  the  level 
of the needle entry site, patient’s position and the 
most direct approach for successful biopsy. Patients 
assumed a supine, prone or lateral position. Expe-
rienced  interventional  radiologists  performed  all 
biopsies.
An 19 gauge outer guiding cannula was always 
used to prevent the flexible 20-gauge needle from 
deviating into the soft tissue.
Core-cut biopsies were taken with the Auto Sure-
cut system as described previously.
Informed consent was obtained from each patient 
at least 24 hours before the interventional procedure.
statistics
All statistical analyses were performed with the sta-
tistical  software  package  SPSS  version  10.0.  The 
chi square test was applied to analyse dichotomous 
variables. Statistical significance was considered as 
P , 0.05.
Results
In  591  of  669  biopsies  (88.3%),  there  were  posi-
tive results that correlated with and ultimately were 
confirmed by subsequent surgery, clinical follow-up 
or autopsy. The accuracy was 87.4%. In 193 of 260 
(74.2%) patients, a suspected malignancy was con-
firmed by surgery. The diagnosis of 13 patients of the 
surgical group was confirmed additionally by autopsy. 
In 50 of 260 (19.2%) patients, a benign lesion was cor-
rectly diagnosed. They had a follow up period of one 
year. At the end of one year a CT scan was performed. 
Seventeen  (6.5%)  patients  were  lost  to  follow-up. 
The first, second and third biopsies had cumulative 
accuracies of 63.6%, 89.2% and 91.5%, respectively 
(P , 0.02) (Fig. 1). In Figures 2 and 3 the number 
of patients and the number of biopsies that were per-
formed are listed.
All histological results are summarized in Figure 3.number of biopsies in diagnosing pulmonary nodules 
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The  median  size  of  pulmonary  nodules  was 
2.8  cm  ±  14.9  (range  0.9–6.3  cm).  The  median 
lesion depth was 1.2 cm ± 1.4 (range 0–6 cm). Pneu-
mothorax was the most frequent complication: 87 
of 260 patients (33.4%) developed a pneumothorax 
but only 10 (3.8%) patients required a   transthoracal 
chest  tube  to  evacuate  the  pneumothorax.  The 
  second most   frequent complication was haemop-
tysis in 12 (4.6%) patients, none of whom required 
any  further    interventional  or  surgical  treatment 
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Figure 1. Correlation between number of biopsies and histopathological accuracy of pulmonary nodular lesions. (P , 0.02).
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Figure 2. Number of patients with a histopathological malignancy diagnosed with 1–5 biopsies (first bar) and correct diagnosis after 1–5 biopsies 
  (second bar).Wehrschuetz et al
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(Table 1).   Otherwise, there were no serious adverse 
events.
Discussion
Percutaneous biopsy of thoracic lesions has become 
established  as  an  effective  and  safe  procedure. 
  Successful  percutaneous  needle  biopsy  of  lung 
lesions has been applied with excellent results and 
few complications.8–10 The key to these procedures 
is the imaging guidance, which allows for the safe 
passage of a needle into the region of interest in the 
lung. In most settings, percutaneous biopsy is the first 
approach to diagnosis.
There is little literature dealing with the question 
of  the  optimal  number  of  biopsies  that  should  be 
obtained for the highest possible accuracy, unless a 
pathologist is on site.
In 669 biopsies, we found that the highest pos-
sible  accuracy  was  obtained  with  three  suitable 
specimens. More biopsies did not have any further 
impact on   diagnostic accuracy. We find it of con-
sequence to obtain three specimens in one setting 
because the   operator uses the same approach via the 
previously positioned outer cannula. More biopsies 
do not improve the   accuracy in the   histopathological 
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Figure 3. Number of patients with a histopathological benign diagnosed with 1–5 biopsies (first bar) and correct diagnosis after 1–5 biopsies (second bar).
Table 1. histological diagnosis of 260 patients with pulmo-
nary lesions. specimens obtained by CT-guided core-cut 
biopsy.
Histology
Benign 50 (19.2%)
  harmatoma 7
  Wegener’s disease 2
  sarckoidosis 2
  Amyloidosis 1
  Non-specific* 38
Lost to follow-up 0 (0%)
Malignant 193 (74.2%)
  Adenocarcinoma 85
  non-small cell 23
  squamous 33
  Metastasis 29
  Undifferentiated carcinoma 17
  BAC 5
  Lymphoma 1
Lost to follow-up 17 (6.5%)
*In the non-specific group no precise diagnosis was obtained by biopsy, 
but  the  benign  nature  of  the  lesion  was  confirmed  during  follow-up 
period.
Table  2.  synopsis  of  complication  rate  in  260  patients 
undergoing CT-guided core-cut biopsy.
complication
Overall 99 (38.1%)
Pneumothorax 87 (33.4%)
  Transthoracal chest tube 10 (3.8%)
haemoptysis 12 (4.6%)number of biopsies in diagnosing pulmonary nodules 
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work-up.  A  strong    reason  for  this  retrospective 
result cannot be addressed. One fact we stress is 
the prefabricated way for the multiple biopsies by 
the outer cannula. Furthermore we state, that there 
are  different  numbers  of  patients  in  the  different 
biopsy groups which makes the data less compara-
ble. Statistically, we found a strong indication, that 
at least three biopsies show the best result in terms 
of accuracy.
In our cohort, we observed a complication rate in 
terms of pneumothorax of 33.4%. Twelve patients 
needed further treatment with a transthoracal chest 
tube to evacuate the pneumothorax. Our results cor-
relate quite well with the literature, in which the 
reported frequency of pneumothorax for CT-guided 
procedures  varies  from  8%  to  64%  (Fig.  2).11–15 
The  median  size  of  our  pulmonary  nodules  was 
2.8 cm ± 14.9 (range 0.9–6.3 cm) and the median 
lesion  depth  was  1.2  cm  ±  1.4  (range  0–6  cm). 
A lesion size # 2 cm, a lesion depth of 0.1 to 2 cm 
and less experienced radiologists are given as the 
strongest parameters predictive of pneumothorax. 
The highest bleeding risk correlates with a lesion 
size # 2 cm, a lesion depth of . 2.1 cm and the 
absence of pleural effusion.16 Finally, for the power 
of this study it is important to mention the multi—
operative specimens obtaining.
The histological results of our cohort also cor-
relate well with those in the literature.17 There is an 
important advantage to be mentioned in terms of 
patient’s  risks.  Obtaining  three  specimens  instead 
of  four  or  five  reduces  the  risk  of  bleeding  and 
pneumothorax.
The  limits  of  this  study  are  not  only  the  small 
patient number. The fact, that there a different num-
bers of patients in the different study groups makes a 
reliable statement on the absolute necessary number 
of core cut biopsies in lung lesions difficult. There-
fore we stress the fact to design a lager prospective 
study with better comparable numbers of patients in 
the different study groups.
Nevertheless,  we  find  that  CT-guided  core-cut 
biopsy of pulmonary nodules is an effective diag-
nostic tool for diagnosing pulmonary lesions. On the 
basis of our data a total number of at least three spec-
imens for every CT-guided core-cut biopsy could 
be recommended on the condition that each core 
shows a well preserved barrel for   histopathological 
work up. However, further prospective studies with 
a greater number of patients and a better distribu-
tion  of  the  patients  between  the  different  biopsy 
groups will be helpful for the confirmation of this 
study data.
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